TECH

Latest SEC Filings & News for TECH

2 most recent filings and news items mentioning TECH. Updated every 60 seconds.

Get this data via API — free tier: 10,000 calls/day
curl "https://api.brieftape.com/v1/tickers/TECH/news?limit=20"

Pull TECH filings straight into your trading bot, model, or app.

Get an API key — free tier: 10,000 calls/day

Bio-Techne to Be Acquired by Merck KGaA in Deal Valued at $11.3 Billion

Merck KGaA entered into a definitive agreement to acquire Bio-Techne for $73 per share, representing an enterprise value of $11.3 billion. This transaction is expected to immediately accretive to sales growth and EBITDA, strengthening Merck's presence in the life sciences market.

View filing at SEC.gov →

Merck To Acquire Bio-Techne For $73 Per Share In Cash At EV Of $11.3B; Deal Expected To Be Immediately Accretive To Sales Growth And EBITDA Pre Margin And EPS Pre Accretive By Year 3 Post-Closing

Merck To Acquire Bio-Techne For $73 Per Share In Cash At EV Of $11.3B; Deal Expected To Be Immediately Accretive To Sales Growth And EBITDA Pre Margin And EPS Pre Accretive By Year 3 Post-Closing

View filing at SEC.gov →
AI-summarized public filings for informational purposes only. Not investment advice. Always verify against the original filing at sec.gov. BriefTape is not a registered investment adviser, broker-dealer, or financial advisor.